132 related articles for article (PubMed ID: 36269138)
1. SARS-CoV-2 seroprevalence study after the first wave among persons living and working in an overcrowded Swiss prison.
Gétaz L; Wolff H; Gonçalves L; Togni G; Stringhini S; Chacowry Pala K; Iten A; Guessous I; Kaiser L; Chappuis F; Baggio S
Int J Prison Health; 2022 Oct; ():. PubMed ID: 36269138
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 Infection Among Incarcerated Individuals and Prison Staff in Lombardy, Italy, March 2020 to February 2021.
Mazzilli S; Tavoschi L; Soria A; Fornili M; Cocca G; Sebastiani T; Scardina G; Cairone C; Arzilli G; Lapadula G; Ceccarelli L; Cocco N; Bartolotti R; De Vecchi S; Placidi G; Rezzonico L; Baglietto L; Giuliani R; Ranieri R
JAMA Netw Open; 2022 Mar; 5(3):e224862. PubMed ID: 35353164
[TBL] [Abstract][Full Text] [Related]
3. A study of SARS-COV-2 outbreaks in US federal prisons: the linkage between staff, incarcerated populations, and community transmission.
Towers S; Wallace D; Walker J; Eason JM; Nelson JR; Grubesic TH
BMC Public Health; 2022 Mar; 22(1):482. PubMed ID: 35277142
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence and Risk Factors for Severe Acute Respiratory Syndrome Coronavirus 2 Among Incarcerated Adult Men in Quebec, Canada, 2021.
Kronfli N; Dussault C; Maheu-Giroux M; Halavrezos A; Chalifoux S; Sherman J; Park H; Del Balso L; Cheng MP; Poulin S; Cox J
Clin Infect Dis; 2022 Aug; 75(1):e165-e173. PubMed ID: 35037053
[TBL] [Abstract][Full Text] [Related]
5. Parallel evolution and differences in seroprevalence of SARS-CoV-2 antibody between patients with cancer and health care workers in a tertiary cancer centre during the first and second wave of COVID-19 pandemic: canSEROcov-II cross-sectional study.
Ladoire S; Rederstorff E; Goussot V; Parnalland S; Briot N; Ballot E; Truntzer C; Ayati S; Bengrine-Lefevre L; Bremaud N; Coudert B; Desmoulins I; Favier L; Fraisse C; Fumet JD; Hennequin A; Hervieu A; Ilie S; Kaderbhai C; Lagrange A; Martin N; Mazilu I; Mayeur D; Palmier R; Simonet-Lamm AL; Vincent J; Zanetta S; Arnould L; Coutant C; Bertaut A; Ghiringhelli F
Eur J Cancer; 2022 Apr; 165():13-24. PubMed ID: 35189537
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 seroprevalence in hospital healthcare workers in Western Switzerland at the end of the second pandemic wave.
Jacot D; von Rotz U; Blondet F; Aebischer O; Matthieu P; De Rham M; Pantaleo G; Marchetti O; Greub G
J Med Microbiol; 2022 Aug; 71(8):. PubMed ID: 35921229
[No Abstract] [Full Text] [Related]
7. COVID-19 among workers of a comprehensive cancer centre between first and second epidemic waves (2020): a seroprevalence study in Catalonia, Spain.
Peremiquel-Trillas P; Saura-Lázaro A; Benavente-Moreno Y; Casabonne D; Loureiro E; Cabrera S; Duran A; Garrote L; Brao I; Trelis J; Galán M; Soler F; Julià J; Cortasa D; Domínguez MÁ; Albasanz-Puig A; Gudiol C; Ramírez-Tarruella D; Muniesa J; Rivas JP; Muñoz-Montplet C; Sedano A; Plans À; Calvo-Cerrada B; Calle C; Clopés A; Carnicer-Pont D; Alemany L; Fernández E
BMJ Open; 2022 Apr; 12(4):e056637. PubMed ID: 35450905
[TBL] [Abstract][Full Text] [Related]
8. Locking out the virus: management of a SARS-CoV-2 outbreak in an Italian prison.
Cerrato F; Esposito M; Drusiani A; Moi I; Franciosi E; Assueri N; Campalastri R; Fioritti A
Int J Prison Health; 2021 May; ():. PubMed ID: 34323430
[TBL] [Abstract][Full Text] [Related]
9. National population prevalence of antibodies to SARS-CoV-2 in Scotland during the first and second waves of the COVID-19 pandemic.
Palmateer NE; Dickson E; Furrie E; Godber I; Goldberg DJ; Gousias P; Jarvis L; Mathie L; Mavin S; McMenamin J; McNeilly TN; Murcia P; Murray J; Reid G; Robertson C; Templeton K; von Wissmann B; Wallace LA; Waugh C; McAuley A
Public Health; 2021 Sep; 198():102-105. PubMed ID: 34411992
[TBL] [Abstract][Full Text] [Related]
10. Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic.
Anand S; Montez-Rath M; Han J; Cadden L; Hunsader P; Kerschmann R; Beyer P; Boyd SD; Garcia P; Dittrich M; Block GA; Parsonnet J; Chertow GM
JAMA Netw Open; 2021 Jul; 4(7):e2116572. PubMed ID: 34251441
[TBL] [Abstract][Full Text] [Related]
11. Suicide attempts and Covid-19 in prison: Empirical findings from 2016 to 2020 in a Swiss prison.
Gétaz L; Wolff H; Golay D; Heller P; Baggio S
Psychiatry Res; 2021 Sep; 303():114107. PubMed ID: 34271371
[TBL] [Abstract][Full Text] [Related]
12. Determining the Prevalence and Incidence of SARS-CoV-2 Infection in Prisons in England: Protocol for a Repeated Panel Survey and Enhanced Outbreak Study.
Plugge E; Burke D; Czachorowski M; Gutridge K; Maxwell F; McGrath N; O'Mara O; O'Moore E; Parkes J
JMIR Res Protoc; 2022 Jan; 11(1):e30749. PubMed ID: 34751157
[TBL] [Abstract][Full Text] [Related]
13. Is There a Temporal Relationship between COVID-19 Infections among Prison Staff, Incarcerated Persons and the Larger Community in the United States?
Wallace D; Eason JM; Walker J; Towers S; Grubesic TH; Nelson JR
Int J Environ Res Public Health; 2021 Jun; 18(13):. PubMed ID: 34206845
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of SARS-CoV-2 antibodies, associated factors, experiences and attitudes of nursing home and home healthcare employees in Switzerland.
West EA; Kotoun OJ; Schori LJ; Kopp J; Kaufmann M; Rasi M; Fehr J; Puhan MA; Frei A;
BMC Infect Dis; 2022 Mar; 22(1):259. PubMed ID: 35296242
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays.
Allen N; Brady M; Carrion Martin AI; Domegan L; Walsh C; Houlihan E; Kerr C; Doherty L; King J; Doheny M; Griffin D; Molloy M; Dunne J; Crowley V; Holmes P; Keogh E; Naughton S; Kelly M; O'Rourke F; Lynagh Y; Crowley B; de Gascun C; Holder P; Bergin C; Fleming C; Ni Riain U; Conlon N;
Microbiol Spectr; 2021 Oct; 9(2):e0039121. PubMed ID: 34585976
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Peru in July and August, 2020: a population-based study.
Álvarez-Antonio C; Meza-Sánchez G; Calampa C; Casanova W; Carey C; Alava F; Rodríguez-Ferrucci H; Quispe AM
Lancet Glob Health; 2021 Jul; 9(7):e925-e931. PubMed ID: 34022148
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study.
Poustchi H; Darvishian M; Mohammadi Z; Shayanrad A; Delavari A; Bahadorimonfared A; Eslami S; Javanmard SH; Shakiba E; Somi MH; Emami A; Saki N; Hormati A; Ansari-Moghaddam A; Saeedi M; Ghasemi-Kebria F; Mohebbi I; Mansour-Ghanaei F; Karami M; Sharifi H; Pourfarzi F; Veisi N; Ghadimi R; Eghtesad S; Niavarani A; Ali Asgari A; Sadeghi A; Sorouri M; Anushiravani A; Amani M; Kaveh S; Feizesani A; Tabarsi P; Keyvani H; Markarian M; Shafighian F; Sima A; Sadjadi A; Radmard AR; Mokdad AH; Sharafkhah M; Malekzadeh R
Lancet Infect Dis; 2021 Apr; 21(4):473-481. PubMed ID: 33338441
[TBL] [Abstract][Full Text] [Related]
18. Association Between Prison Crowding and COVID-19 Incidence Rates in Massachusetts Prisons, April 2020-January 2021.
Leibowitz AI; Siedner MJ; Tsai AC; Mohareb AM
JAMA Intern Med; 2021 Oct; 181(10):1315-1321. PubMed ID: 34369964
[TBL] [Abstract][Full Text] [Related]
19. Antibody tests for identification of current and past infection with SARS-CoV-2.
Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of the SARS-CoV-2 virus in the population of the southern Switzerland (Canton Ticino) - cohort study, results at 12 months.
Beretta O; Casati Pagani S; Lazzaro M; Merlani G; Bouvier Gallacchi M
Swiss Med Wkly; 2021 Dec; 151():w30116. PubMed ID: 34964622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
